31 research outputs found
Marketing of unproven stem cell-based interventions:A call to action
Get PDFCommercial promotion of unsupported therapeutic uses of stem cells is a global problem that has proven resistant to regulatory efforts. Here, we suggest a coordinated approach at the national and international levels focused on engagement, harmonization, and enforcement to reduce the risks associated with direct-to-consumer marketing of unproven stem cell treatments
False sense of security offered by zero-price liability rules? Research exceptions in the US, Europe and Japan in an open innovation context
No full textReshaping Belgian patent law:The revision of the research exemption and the introduction of a compulsory license for public health
No full text
The interaction between agencies, networks and the European Commission in emerging regulatory constellations : a comparative analysis of the European telecom sector and the European patent system
No full text
Using Compulsory Licences as a Governance Tool: The Need for Greater Effectiveness and Policy Coherence
No full textReshaping Belgian patent law: The revision of the research exemption and the introduction of a compulsory license for public health
No full text
False sense of security offered by zero-price liability rules? Research exceptions in the US, Europe and Japan in an open innovation context
No full text
